Related Experiment Videos
[Production and function of the monocyte cytotoxic factor (MCF)]
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|June 1, 1987
Summary
Monocytes produce novel soluble factors, monocyte cytotoxic factors (MCF), that effectively lyse various tumor cells, including fresh human tumors. These factors show potential as a new therapeutic agent for cancer treatment.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Context:
- Monocytes are key immune cells involved in tumor surveillance.
- Tumor cells often develop resistance to conventional therapies.
- Understanding monocyte-derived cytotoxic mechanisms is crucial for developing new cancer treatments.
Purpose:
- To isolate and characterize novel soluble factors produced by monocytes that exhibit tumor cell-lysing activity.
- To investigate the phenotype of monocytes involved in MCF production.
- To determine the characteristics and lytic potential of MCF against various tumor cells, including fresh human tumors.
Summary:
- Monocytes isolated by adherence produced soluble factors, termed monocyte cytotoxic factors (MCF), upon co-culture with K562 cells.
- MCF demonstrated lytic activity against K562 and other tumor cells, including fresh autologous and allogeneic human tumor cells.
- MCF activity was enhanced by actinomycin D and augmented by interferon-alpha or -gamma, and its proteinaceous nature was confirmed through enzymatic degradation studies.
Impact:
- MCF represents a novel cytokine with potent cytotoxic activity against a range of tumor cells, including those resistant to TNF.
- MCF's ability to lyse fresh human tumor cells, independent of TNF, LT, IFN, or IL-1, highlights its unique therapeutic potential.
- These findings suggest MCF as a promising candidate for developing new immunotherapies against various cancers.